Zhejiang Dayang Biotech Group Co (003017.SZ) stock: key figures, P/E, revenue and dividend

Materials · Commodity Chemicals · China · ISIN CNE100004736

Price
22.32 CNY
Market cap
2.25 bn CNY
P/E (2025)
22.53
P/S (2025)
2.15
Dividend yield
2.69 %
Net margin
9.55 %
Return on equity (ROE)
8.82 %
Return on assets (ROA)
5.49 %

Zhejiang Dayang Biotech Group Co financials

Fiscal year20242025
Revenue909.96 m CNY1.05 bn CNY
Gross profit171.24 m CNY239.39 m CNY
Operating income75.37 m CNY123.20 m CNY
EBIT78.93 m CNY111.14 m CNY
Net income63.75 m CNY99.85 m CNY
Diluted EPS – continuing operations0.78 CNY0.99 CNY

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Zhejiang Dayang Biotech Group Co

Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium bicarbonate, ammonium chloride, manufactures and sales bicarbonate food and feed additives; veterinary drugs; potassium bicarbonate; and ammonium chloride. It also provides 2-chloro-6-fluorobenzoic acid, fluorobenzaldehyde, and fluorobenzyl chloride. In addition, it offers aminopropionate hydrochloride. Further, it engages in the wholesale and retail of pharmaceutical intermediates; and research and development of industrial enzyme preparations and biological feeds. The company was founded in 1976 and is based in Jiande, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.